Tarsus Pharmaceuticals, Inc. (TARS) · Insider trading
What Tarsus Pharmaceuticals's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$19.96M
9 insiders, 64% under a plan
Net, 12 months
−$19.96M
bought less sold
Latest filing
2026-09-17
filings read to 2026-10-19
Who traded, two years
| Insider | Bought | Sold | Trades | Last trade | Holds after |
|---|---|---|---|---|---|
| Azamian Bobak R.Director, President/CEO and Board Chair | – | $7.28M | 16 | 2026-09-04 | – |
| Link William J PHDDirector | – | $6.03M | 14 | 2026-09-15 | 95,312 |
| Whitfield Dianne C.Chief Human Resources Officer | – | $3.01M | 11 | 2026-03-19 | 35,028 |
| Lin Elizabeth YeuChief Medical Officer | – | $2.40M | 12 | 2026-09-04 | 7,933 |
| Neervannan SeshadriChief Operating Officer | – | $2.36M | 9 | 2026-09-04 | 78,532 |
| Mottiwala AzizChief Commercial Officer | – | $2.16M | 7 | 2026-03-19 | 61,480 |
| Farrow Jeffrey SSee Remarks | – | $2.05M | 8 | 2026-06-16 | 56,801 |
| Wahl BryanGeneral Counsel | – | $1.31M | 6 | 2026-03-19 | 63,959 |
| Goodrich KatherineDirector | – | $183,384 | 1 | 2026-06-15 | 2,233 |
Open-market purchases and sales
Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Holds after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | Link William J PHDDirector | Saleplan | 11,675 | 78.33 | $914,503 | 95,312 | Form 4 |
| 2026-09-15 | Link William J PHDDirector | Saleplan | 759 | 79.00 | $59,961 | 94,553 | Form 4 |
| 2026-09-15 | Link William J PHDDirector | Saleplan | 66 | 80.01 | $5,281 | 94,487 | Form 4 |
| 2026-09-04 | Neervannan SeshadriChief Operating Officer | Saleplan | 4,564 | 85.00 | $387,940 | 78,532 | Form 4 |
| 2026-09-04 | Azamian Bobak R.Director, President/CEO and Board Chair | Saleplanindirect | 7,100 | 90.27 | $640,917 | 830,891 | Form 4 |
| 2026-09-04 | Azamian Bobak R.Director, President/CEO and Board Chair | Saleplanindirect | 2,900 | 91.27 | $264,683 | 827,991 | Form 4 |
| 2026-09-04 | Lin Elizabeth YeuChief Medical Officer | Saleplan | 5,387 | 85.00 | $457,895 | 7,933 | Form 4 |
| 2026-09-04 | Lin Elizabeth YeuChief Medical Officer | Saleplan | 5,386 | 90.00 | $484,740 | 2,547 | Form 4 |
| 2026-09-04 | Lin Elizabeth YeuChief Medical Officer | Saleplanindirect | 1,590 | 85.00 | $135,150 | 3,180 | Form 4 |
| 2026-09-04 | Lin Elizabeth YeuChief Medical Officer | Saleplanindirect | 1,590 | 90.00 | $143,100 | 1,590 | Form 4 |
| 2026-09-02 | Azamian Bobak R.Director, President/CEO and Board Chair | Saleplanindirect | 10,000 | 80.06 | $800,600 | 837,991 | Form 4 |
| 2026-09-02 | Lin Elizabeth YeuChief Medical Officer | Saleplan | 5,387 | 80.00 | $430,960 | 13,320 | Form 4 |
| 2026-09-02 | Lin Elizabeth YeuChief Medical Officer | Saleplanindirect | 1,590 | 80.00 | $127,200 | 4,770 | Form 4 |
| 2026-09-01 | Lin Elizabeth YeuChief Medical Officer | Saleplan | 4,601 | 73.86 | $339,830 | 18,707 | Form 4 |
| 2026-06-17 | Azamian Bobak R.Director, President/CEO and Board Chair | Saleplanindirect | 4,582 | 61.24 | $280,602 | 853,409 | Form 4 |
| 2026-06-17 | Azamian Bobak R.Director, President/CEO and Board Chair | Saleplanindirect | 5,418 | 61.81 | $334,887 | 847,991 | Form 4 |
| 2026-06-16 | Farrow Jeffrey SSee Remarks | Sale | 14,396 | 60.95 | $877,436 | 56,801 | Form 4 |
| 2026-06-15 | Link William J PHDDirector | Saleplan | 10,572 | 61.97 | $655,147 | 108,714 | Form 4 |
| 2026-06-15 | Link William J PHDDirector | Saleplan | 1,928 | 62.94 | $121,348 | 106,786 | Form 4 |
| 2026-06-15 | Goodrich KatherineDirector | Saleplan | 2,954 | 62.08 | $183,384 | 2,233 | Form 4 |
| 2026-03-20 | Neervannan SeshadriChief Operating Officer | Saleplan | 2,989 | 66.75 | $199,516 | 82,791 | Form 4 |
| 2026-03-19 | Farrow Jeffrey SSee Remarks | Sale | 2,186 | 67.00 | $146,462 | 43,316 | Form 4 |
| 2026-03-19 | Mottiwala AzizChief Commercial Officer | Sale | 4,440 | 67.00 | $297,480 | 61,480 | Form 4 |
| 2026-03-19 | Neervannan SeshadriChief Operating Officer | Sale | 4,589 | 67.00 | $307,463 | 85,780 | Form 4 |
| 2026-03-19 | Azamian Bobak R.Director, President/CEO and Board Chair | Sale | 11,964 | 67.00 | $801,588 | 33,421 | Form 4 |
| 2026-03-19 | Whitfield Dianne C.Chief Human Resources Officer | Sale | 4,174 | 67.00 | $279,658 | 35,028 | Form 4 |
| 2026-03-19 | Wahl BryanGeneral Counsel | Sale | 4,231 | 67.00 | $283,477 | 63,959 | Form 4 |
| 2026-03-19 | Lin Elizabeth YeuChief Medical Officer | Sale | 390 | 67.00 | $26,130 | 23,308 | Form 4 |
| 2026-03-18 | Farrow Jeffrey SSee Remarks | Sale | 2,133 | 68.71 | $146,558 | 45,502 | Form 4 |
| 2026-03-18 | Mottiwala AzizChief Commercial Officer | Sale | 4,330 | 68.71 | $297,514 | 65,920 | Form 4 |
| 2026-03-18 | Neervannan SeshadriChief Operating Officer | Sale | 3,610 | 68.71 | $248,043 | 90,369 | Form 4 |
| 2026-03-18 | Azamian Bobak R.Director, President/CEO and Board Chair | Sale | 11,667 | 68.71 | $801,640 | 45,385 | Form 4 |
| 2026-03-18 | Whitfield Dianne C.Chief Human Resources Officer | Sale | 4,071 | 68.71 | $279,718 | 39,202 | Form 4 |
| 2026-03-18 | Wahl BryanGeneral Counsel | Sale | 4,125 | 68.71 | $283,429 | 68,190 | Form 4 |
| 2026-03-18 | Lin Elizabeth YeuChief Medical Officer | Sale | 379 | 68.71 | $26,041 | 23,698 | Form 4 |
| 2026-03-17 | Farrow Jeffrey SSee Remarks | Sale | 2,111 | 69.42 | $146,546 | 47,635 | Form 4 |
| 2026-03-17 | Mottiwala AzizChief Commercial Officer | Sale | 4,286 | 69.42 | $297,534 | 70,250 | Form 4 |
| 2026-03-17 | Neervannan SeshadriChief Operating Officer | Sale | 3,125 | 69.42 | $216,938 | 93,979 | Form 4 |
| 2026-03-17 | Azamian Bobak R.Director, President/CEO and Board Chair | Sale | 10,972 | 69.42 | $761,676 | 57,052 | Form 4 |
| 2026-03-17 | Whitfield Dianne C.Chief Human Resources Officer | Sale | 4,029 | 69.42 | $279,693 | 43,273 | Form 4 |
44 more
| 2026-03-17 | Wahl BryanGeneral Counsel | Sale | 4,084 | 69.42 | $283,511 | 72,315 | Form 4 |
| 2026-03-17 | Lin Elizabeth YeuChief Medical Officer | Sale | 375 | 69.42 | $26,032 | 24,077 | Form 4 |
| 2026-03-16 | Link William J PHDDirector | Saleplan | 3,629 | 68.09 | $247,099 | 125,203 | Form 4 |
| 2026-03-16 | Link William J PHDDirector | Saleplan | 8,378 | 69.03 | $578,333 | 116,825 | Form 4 |
| 2026-03-16 | Link William J PHDDirector | Saleplan | 493 | 69.75 | $34,387 | 116,332 | Form 4 |
| 2026-03-04 | Neervannan SeshadriChief Operating Officer | Saleplan | 8,366 | 76.67 | $641,421 | 70,817 | Form 4 |
| 2026-01-02 | Whitfield Dianne C.Chief Human Resources Officer | Saleplan | 5,715 | 80.09 | $457,714 | 33,243 | Form 4 |
| 2026-01-02 | Whitfield Dianne C.Chief Human Resources Officer | Saleplan | 8,122 | 80.71 | $655,527 | 25,121 | Form 4 |
| 2026-01-02 | Whitfield Dianne C.Chief Human Resources Officer | Saleplan | 835 | 81.90 | $68,386 | 24,286 | Form 4 |
| 2026-01-02 | Whitfield Dianne C.Chief Human Resources Officer | Saleplan | 893 | 82.93 | $74,056 | 23,393 | Form 4 |
| 2025-12-24 | Azamian Bobak R.Director, President/CEO and Board Chair | Saleplanindirect | 5,443 | 82.41 | $448,558 | 858,548 | Form 4 |
| 2025-12-24 | Azamian Bobak R.Director, President/CEO and Board Chair | Saleplanindirect | 557 | 83.54 | $46,532 | 857,991 | Form 4 |
| 2025-12-16 | Whitfield Dianne C.Chief Human Resources Officer | Saleplan | 7,397 | 80.10 | $592,500 | 38,958 | Form 4 |
| 2025-12-16 | Lin Elizabeth YeuChief Medical Officer | Sale | 2,078 | 79.50 | $165,201 | 21,941 | Form 4 |
| 2025-12-15 | Link William J PHDDirector | Saleplan | 5,046 | 80.80 | $407,717 | 136,286 | Form 4 |
| 2025-12-15 | Link William J PHDDirector | Saleplan | 6,306 | 81.75 | $515,516 | 129,980 | Form 4 |
| 2025-12-15 | Link William J PHDDirector | Saleplan | 1,148 | 82.39 | $94,584 | 128,832 | Form 4 |
| 2025-12-15 | Link William J PHDDirector | Saleplanindirect | 5,680 | 80.71 | $458,433 | 4,766 | Form 4 |
| 2025-12-15 | Link William J PHDDirector | Saleplanindirect | 4,766 | 81.50 | $388,429 | 0 | Form 4 |
| 2025-09-24 | Azamian Bobak R.Director, President/CEO and Board Chair | Saleplanindirect | 6,000 | 55.37 | $332,220 | 812,106 | Form 4 |
| 2025-09-08 | Link William J PHDDirector | Sale | 27,116 | 57.00 | $1.55M | 143,332 | Form 4 |
| 2025-08-11 | Azamian Bobak R.Director, President/CEO and Board Chair | Saleplanindirect | 6,000 | 50.00 | $300,000 | 818,106 | Form 4 |
| 2025-06-17 | Farrow Jeffrey SSee Remarks | Sale | 13,608 | 40.42 | $550,035 | 36,704 | Form 4 |
| 2025-06-16 | Lin Elizabeth YeuChief Medical Officer | Sale | 1,006 | 41.08 | $41,326 | 7,694 | Form 4 |
| 2025-06-09 | Mottiwala AzizChief Commercial Officer | Saleplan | 17,500 | 43.76 | $765,800 | 47,557 | Form 4 |
| 2025-03-24 | Azamian Bobak R.Director, President/CEO and Board Chair | Saleindirect | 6,000 | 50.00 | $300,000 | 824,106 | Form 4 |
| 2025-03-20 | Farrow Jeffrey SSee Remarks | Sale | 1,186 | 50.11 | $59,430 | 22,431 | Form 4 |
| 2025-03-20 | Azamian Bobak R.Director, President/CEO and Board Chair | Sale | 8,534 | 50.11 | $427,639 | 53,635 | Form 4 |
| 2025-03-20 | Whitfield Dianne C.Chief Human Resources Officer | Sale | 2,137 | 50.11 | $107,085 | 46,355 | Form 4 |
| 2025-03-20 | Wahl BryanGeneral Counsel | Sale | 3,084 | 50.11 | $154,539 | 51,712 | Form 4 |
| 2025-03-20 | Neervannan SeshadriChief Operating Officer | Sale | 2,435 | 50.11 | $122,018 | 79,682 | Form 4 |
| 2025-03-20 | Mottiwala AzizChief Commercial Officer | Sale | 3,365 | 50.11 | $168,620 | 65,057 | Form 4 |
| 2025-03-19 | Farrow Jeffrey SSee Remarks | Sale | 1,254 | 47.40 | $59,440 | 23,617 | Form 4 |
| 2025-03-19 | Azamian Bobak R.Director, President/CEO and Board Chair | Sale | 8,551 | 47.40 | $405,317 | 62,169 | Form 4 |
| 2025-03-19 | Whitfield Dianne C.Chief Human Resources Officer | Sale | 2,259 | 47.40 | $107,077 | 48,492 | Form 4 |
| 2025-03-19 | Wahl BryanGeneral Counsel | Sale | 3,261 | 47.40 | $154,571 | 54,796 | Form 4 |
| 2025-03-19 | Neervannan SeshadriChief Operating Officer | Sale | 2,543 | 47.40 | $120,538 | 82,117 | Form 4 |
| 2025-03-19 | Mottiwala AzizChief Commercial Officer | Sale | 3,557 | 47.40 | $168,602 | 68,422 | Form 4 |
| 2025-03-18 | Farrow Jeffrey SSee Remarks | Sale | 1,284 | 46.29 | $59,436 | 24,871 | Form 4 |
| 2025-03-18 | Azamian Bobak R.Director, President/CEO and Board Chair | Sale | 7,131 | 46.29 | $330,094 | 70,720 | Form 4 |
| 2025-03-18 | Whitfield Dianne C.Chief Human Resources Officer | Sale | 2,315 | 46.29 | $107,161 | 50,751 | Form 4 |
| 2025-03-18 | Wahl BryanGeneral Counsel | Sale | 3,341 | 46.29 | $154,655 | 58,057 | Form 4 |
| 2025-03-18 | Neervannan SeshadriChief Operating Officer | Sale | 2,605 | 46.29 | $120,585 | 84,660 | Form 4 |
| 2025-03-18 | Mottiwala AzizChief Commercial Officer | Sale | 3,643 | 46.29 | $168,634 | 71,979 | Form 4 |
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
35 × option exercise4 × gift
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-15 | Pyott David e IDirector | Option exercise M | +201 | – | 9,575 | Form 4 |
| 2026-09-15 | Yarno Wendy LDirector | Option exercise M | +302 | – | 16,956 | Form 4 |
| 2026-09-15 | Link William J PHDDirector | Option exercise M | +201 | – | 106,987 | Form 4 |
| 2026-06-15 | Farrow Jeffrey SSee Remarks | Option exercise M | +27,881 | – | 71,197 | Form 4 |
| 2026-06-12 | Yarno Wendy LDirector | Option exercise M | +2,954 | – | 16,654 | Form 4 |
| 2026-06-12 | Link William J PHDDirector | Option exercise M | +2,954 | – | 119,286 | Form 4 |
| 2026-06-12 | Chaudhuri BhaskarDirector | Option exercise M | +2,954 | – | 11,654 | Form 4 |
| 2026-06-12 | Morrison Scott WDirector | Option exercise M | +2,954 | – | 7,638 | Form 4 |
| 2026-06-12 | Goldberg Andrew D.Director | Option exercise M | +2,954 | – | 19,654 | Form 4 |
| 2026-06-12 | Goodrich KatherineDirector | Option exercise M | +2,954 | – | 5,187 | Form 4 |
| 2026-04-24 | Pyott David e IDirector | Option exercise M | +1,383 | – | 1,383 | Form 4 |
| 2026-03-15 | Farrow Jeffrey SSee Remarks | Option exercise M | +13,042 | – | 49,746 | Form 4 |
| 2026-03-15 | Mottiwala AzizChief Commercial Officer | Option exercise M | +26,482 | – | 74,536 | Form 4 |
| 2026-03-15 | Neervannan SeshadriChief Operating Officer | Option exercise M | +26,287 | – | 97,104 | Form 4 |
| 2026-03-15 | Azamian Bobak R.Director, President/CEO and Board Chair | Option exercise M | +66,274 | – | 68,024 | Form 4 |
| 2026-03-15 | Whitfield Dianne C.Chief Human Resources Officer | Option exercise M | +23,909 | – | 47,302 | Form 4 |
| 2026-03-15 | Wahl BryanGeneral Counsel | Option exercise M | +24,236 | – | 76,399 | Form 4 |
| 2026-03-15 | Lin Elizabeth YeuChief Medical Officer | Option exercise M | +2,511 | – | 24,452 | Form 4 |
| 2025-12-16 | Neervannan SeshadriChief Operating Officer | Gift G | −950 | – | 79,183 | Form 4 |
| 2025-12-16 | Neervannan SeshadriChief Operating Officer | Gift G | +475 | – | 475 | Form 4 |
| 2025-12-15 | Goodrich KatherineDirector | Option exercise M | +2,233 | – | 2,233 | Form 4 |
| 2025-12-15 | Lin Elizabeth YeuChief Medical Officer | Option exercise M | +6,819 | – | 24,019 | Form 4 |
| 2025-12-04 | Azamian Bobak R.Director, President/CEO and Board Chair | Gift G | −51,885 | – | 1,750 | Form 4 |
| 2025-09-16 | Link William J PHDDirector | Gift G | −2,000 | – | 141,332 | Form 4 |
| 2025-09-15 | Morrison Scott WDirector | Option exercise M | +1,334 | – | 4,684 | Form 4 |
| 2025-06-16 | Farrow Jeffrey SSee Remarks | Option exercise M | +27,881 | – | 50,312 | Form 4 |
| 2025-06-13 | Lin Elizabeth YeuChief Medical Officer | Option exercise M | +3,350 | – | 8,700 | Form 4 |
| 2025-06-13 | Link William J PHDDirector | Option exercise M | +3,350 | – | 170,448 | Form 4 |
| 2025-06-13 | Morrison Scott WDirector | Option exercise M | +3,350 | – | 3,350 | Form 4 |
| 2025-06-13 | Yarno Wendy LDirector | Option exercise M | +3,350 | – | 13,700 | Form 4 |
| 2025-06-13 | Goldberg Andrew D.Director | Option exercise M | +3,350 | – | 16,700 | Form 4 |
| 2025-06-13 | Chaudhuri BhaskarDirector | Option exercise M | +3,350 | – | 8,700 | Form 4 |
| 2025-03-15 | Mottiwala AzizChief Commercial Officer | Option exercise M | +20,957 | – | 75,622 | Form 4 |
| 2025-03-15 | Neervannan SeshadriChief Operating Officer | Option exercise M | +21,264 | – | 87,265 | Form 4 |
| 2025-03-15 | Wahl BryanGeneral Counsel | Option exercise M | +19,213 | – | 61,398 | Form 4 |
| 2025-03-15 | Whitfield Dianne C.Chief Human Resources Officer | Option exercise M | +18,885 | – | 53,066 | Form 4 |
| 2025-03-15 | Azamian Bobak R.Director, President/CEO and Board Chair | Option exercise M | +51,395 | – | 77,851 | Form 4 |
| 2025-03-15 | Farrow Jeffrey SSee Remarks | Option exercise M | +8,019 | – | 26,155 | Form 4 |
| 2025-03-07 | Goldberg Andrew D.Director | Option exercise M | +7,000 | 12.89 | 13,350 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.